A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients (Q28241872)
scientific article (publication date: November 1994)
Language:
Current Data About A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients
(P31) (Q13442814)

(P304) 1204-10

(P407) (Q1860)

(P433) 11

(P478) 129

(P577) +1994-11-00T00:00:00Z

(P921) (Q269829)

(Q6934595)

(P1433) (Q15764793)

(P1476) "A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients" (language: en)

(P2093) T J Babineau
(P1545) 1

A Hackford
(P1545) 2

A Kenler
(P1545) 3

B Bistrian
(P1545) 4

R A Forse
(P1545) 5

P G Fairchild
(P1545) 6

S Heard
(P1545) 7

M Keroack
(P1545) 8

P Caushaj
(P1545) 9

P Benotti
(P1545) 10

other details
description scientific article (publication date: November 1994)

External Links
(P356) 10.1001/ARCHSURG.1994.01420350102014
(P698) 7979954
(P3181) 2386342